Christophe Durand

Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year.

Cenexi HSC SAS is a French company founded in 2004 that specializes in the development and manufacturing of sterile and biological products. The company is based in Fontenay-sous-Bois, France. The company's services include formulation, analytical and galenic development, industrial transfer, and regulatory support.

Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France.

Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cenexi 2 SASU is a contract manufacturing and development organization of pharmaceutical products. The company is based in Fontenay-sous-Bois, France. The French company was founded in 2016. The CEO is Christophe Durand.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.